UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q3 2022 | 2022-11-07 | Future report Set alerts | |
| Q2 2022 | 2022-08-09 | 0.18 | 0.18 |
| Q1 2022 | 2022-05-10 | 0.18 | 0.18 |
| Q4 2021 | 2022-02-15 | 0.22 | 0.22 |
| Q3 2021 | 2021-11-09 | 0.20 | 0.20 |
| Q2 2021 | 2021-08-09 | 0.22 | 0.22 |
| Q1 2021 | 2021-05-10 | 0.01 | 0.01 |
| Q4 2020 | 2021-02-16 | 0.20 | 0.20 |
| Q3 2020 | 2020-11-05 | 0.16 | 0.16 |
| Q2 2020 | 2020-08-10 | 0.12 | 0.12 |
| 2016-05-19 | Reiterated Rating | Oppenheimer | Outperform | $32.00 |
| 2016-05-19 | Reiterated Rating | Oppenheimer Holdings Inc. | Outperform | $32.00 |
| 2016-05-10 | Boost Price Target | Oppenheimer | Outperform | $25.00 to $32.00 |
| 2016-05-02 | Boost Price Target | Topeka Capital Markets | Buy | $27.00 to $28.00 |
| 2016-05-02 | Reiterated Rating | Oppenheimer | Buy | |
| 2016-05-02 | Reiterated Rating | Canaccord Genuity | Buy | $31.00 |
| 2016-03-29 | Reiterated Rating | Canaccord Genuity | Buy | $28.00 |
| 2016-02-04 | Lower Price Target | Barclays | Overweight | $30.00 to $28.00 |
| 2016-02-04 | Reiterated Rating | Canaccord Genuity | Buy | $28.00 |
| 2016-02-04 | Upgrade | Chardan Capital | Buy | $27.00 |
| 2016-02-04 | Lower Price Target | Barclays PLC | Overweight | $30.00 to $28.00 |
| 2016-01-14 | Reiterated Rating | Canaccord Genuity | Buy | $28.00 |
| 2016-01-11 | Upgrade | Ladenburg Thalmann | Neutral to Buy | $29.00 |
| 2015-12-16 | Upgrade | Wunderlich | Hold to Buy | $28.00 |
| 2015-11-10 | Boost Price Target | Benchmark Co. | Buy | $25.00 to $32.00 |
| 2015-11-10 | Downgrade | Wunderlich | Buy to Hold | $26.00 to $28.00 |
| 2015-11-03 | Boost Price Target | Oppenheimer | Outperform | $21.00 to $25.00 |
| 2015-11-03 | Boost Price Target | Canaccord Genuity | Buy | $26.00 to $28.00 |
| 2015-11-03 | Boost Price Target | Chardan Capital | Buy | $21.00 to $27.00 |
| 2015-11-02 | Boost Price Target | Topeka Capital Markets | Buy | $24.00 to $27.00 |
| 2015-11-02 | Boost Price Target | Wunderlich | Buy | $25.00 to $26.00 |
| 2015-10-15 | Initiated Coverage | Ladenburg Thalmann | Neutral | $22.00 |
| 2015-10-05 | Reiterated Rating | Canaccord Genuity | Buy | $26.00 |
| 2015-09-03 | Reiterated Rating | Canaccord Genuity | Buy | |
| 2015-08-18 | Reiterated Rating | Chardan Capital | Buy | $21.00 |
| 2015-08-12 | Reiterated Rating | Canaccord Genuity | Buy | $26.00 |
| 2015-07-31 | Reiterated Rating | Canaccord Genuity | Buy | $25.00 to $26.00 |
| 2015-07-08 | Reiterated Rating | Canaccord Genuity | Buy | $25.00 |
| 2015-05-26 | Boost Price Target | Barclays | Overweight | $23.00 to $25.00 |
| 2015-05-05 | Lower Price Target | Topeka Capital Markets | Buy | $26.00 to $24.00 |
| 2015-05-05 | Set Price Target | Oppenheimer | Buy | $23.00 |
| 2015-05-05 | Upgrade | Chardan Capital | Neutral to Buy | $15.00 to $21.00 |
| 2015-05-04 | Set Price Target | Canaccord Genuity | Buy | $27.00 |
| 2015-04-26 | Reiterated Rating | Canaccord Genuity | Buy | $27.00 |
| 2015-04-16 | Initiated Coverage | Canaccord Genuity | Buy | $27.00 to $27.00 |
| 2015-03-16 | Boost Price Target | Topeka Capital Markets | Buy | $21.00 to $26.00 |
| 2015-03-13 | Boost Price Target | Benchmark Co. | Buy | $22.00 to $25.00 |
| 2015-03-09 | Boost Price Target | Wunderlich | Buy | $21.00 to $24.00 |
| 2015-01-29 | Reiterated Rating | Wunderlich | Positive | |
| 2015-01-12 | Boost Price Target | Barclays | Overweight | $19.00 to $23.00 |
| 2015-01-07 | Set Price Target | Wunderlich | Buy | $20.00 |
| 2014-11-25 | Reiterated Rating | Wunderlich | Buy | $17.00 to $20.00 |
| 2014-11-14 | Upgrade | Oppenheimer | Market Perform to Outperform | $19.00 |
| 2014-10-31 | Upgrade | Wunderlich | Hold to Buy | $14.00 to $17.00 |
| 2014-10-31 | Upgrade | Chardan Capital Markets | Sell to Neutral | $15 |
| 2014-10-31 | Reiterated Rating | Compass Point | Buy | $14.00 to $17.00 |
| 2014-10-30 | Boost Price Target | Topeka Capital Markets | Buy | $16.00 to $18.00 |
| 2014-07-31 | Lower Price Target | Topeka Capital Markets | Buy | $19.00 to $16.00 |
| 2014-07-31 | Lower Price Target | Wunderlich | Hold | $16.00 to $14.00 |
| 2014-06-12 | Downgrade | Chardan Capital Markets | Neutral to Sell | $13 |
| 2014-06-12 | Downgrade | Chardan Capital | Neutral to Sell | $13.00 |
| 2014-05-01 | Reiterated | Chardan Capital Markets | Neutral | $17 to $13 |
| 2014-05-01 | Downgrade | Wunderlich | Buy to Hold | $20.00 to $16.00 |
| 2014-05-01 | Lower Price Target | Chardan Capital | Neutral | $17.00 to $13.00 |
| 2013-10-17 | Downgrade | Wedbush | Neutral | |
| 2013-10-08 | Lower Price Target | Barclays | Overweight | $24.00 to $23.00 |
| 2013-10-08 | Downgrade | Oppenheimer | Outperform to Market Perform | $24.00 |
| 2013-10-04 | Reiterated | Chardan Capital Markets | Neutral | $14 |
| 2013-10-04 | Reiterated Rating | Chardan Capital | Neutral | $14.00 |
| 2013-10-03 | Lower Price Target | Wunderlich | Buy | $23.00 to $20.00 |
| 2013-10-03 | Reiterated Rating | Topeka Capital Markets | Buy | $20.00 to $18.00 |
| 2013-10-03 | Downgrade | Sterne Agee CRT | Buy to Neutral | |
| 2013-07-24 | Reiterated | The Benchmark Company | Buy | $21 to $20 |
| 2013-07-03 | Reiterated | Wunderlich | Buy | $19 to $23 |
| 2013-06-18 | Reiterated | Chardan Capital Markets | Hold | $15 to $18 |
| 2013-05-03 | Downgrade | Chardan Capital Markets | Buy to Hold | $15 |
| 2013-01-31 | Reiterated | Chardan Capital Markets | Buy | $19 to $17 |
| 2013-01-28 | Upgrade | Chardan Capital Markets | Hold to Buy | $14 to $19 |
| 2012-05-03 | Reiterated | Cantor Fitzgerald | Buy | $40 to $35 |
| 2012-04-19 | Reiterated | Wunderlich | Buy | $36 to $33 |
| 2011-09-30 | Upgrade | The Benchmark Company | Hold to Buy | $31 |
| 2011-07-06 | Reiterated | Sterne Agee | Buy | $26 to $35 |
| 2011-04-28 | Reiterated | Wunderlich | Hold | $27 to $32 |
| 2011-04-28 | Reiterated | RBC Capital Mkts | Sector Perform | $24 to $28 |
| 2011-04-28 | Reiterated | Barclays Capital | Overweight | $32 to $34 |
| 2016-05-19 | Reiterated Rating | Oppenheimer | Outperform | $32.00 |
| 2016-05-19 | Reiterated Rating | Oppenheimer Holdings Inc. | Outperform | $32.00 |
| 2016-05-10 | Boost Price Target | Oppenheimer | Outperform | $25.00 to $32.00 |
| 2016-05-02 | Boost Price Target | Topeka Capital Markets | Buy | $27.00 to $28.00 |
| 2016-05-02 | Reiterated Rating | Oppenheimer | Buy |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In CEVA 132 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| BlackRock Inc. | 3.88M |
| Vanguard Group, Inc | 2.58M |
| BlackRock Fund Advisors | 1.64M |
| STATE STREET CORP | 1.03M |
| RIMA SENVEST MANAGEMENT, L.L.C. | 0.86M |
| LORD, ABBETT & CO. LLC | 0.85M |
| DIMENSIONAL FUND ADVISORS LP | 0.70M |
| OAKTOP CAPITAL MANAGEMENT II, L.P. | 0.63M |
| BlackRock Institutional Trust Company, N.A. | 0.56M |
| RICE HALL JAMES & ASSOCIATES, LLC | 0.51M |
| Neuberger Berman Group LLC | 0.49M |
| DISCIPLINED GROWTH INVESTORS INC /MN | 0.43M |
| AWM Investment Company, Inc. | 0.42M |
| GEODE CAPITAL MANAGEMENT, LLC | 0.41M |
| GRANAHAN INVESTMENT MANAGEMENT INC/MA | 0.41M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| MARXE AUSTIN W & GREENHOUSE DAVID M | 10.37% (2122178) | ADEP / ALCS / ASTC / ASYS / BTUI / BWEN / CACH / CDTI / CEVA / CLRX / CRMB / CYCC / DAEG / DOVR / ERI / ETRM / HEAR / INO / ISNS / ITI / LRAD / LTBR / MAG / MFI / OPXA / OVRL / PFSW / PLUG / PRKR / PTN / RGDX / RVLT / TGEN / URRE / VPCO / WPCS / |
| RIMA SENVEST MANAGEMENT, L.L.C. | 9.89% (2024991) | CEVA / GCAP / IMMR / RAS / SNMX / |
| MCMANAMON PETER | 1.32% (270021) | CEVA / |
| WERTHEIZER GIDEON Chief Executive Officer | 0.50% (101552) | CEVA / |
| Arieli Yaniv Chief Financial Officer | 0.18% (36588) | CEVA / |
| OHANA ISSACHAR EVP Worldwide Sales | 0.14% (27929) | CEVA / |
| SILVER LOUIS | 0.08% (16672) | CEVA / DSPG / |
| NILSSON SVEN CHRISTER | 0.07% (15282) | CEVA / S / |
| MANN BRUCE | 0.07% (13422) | CEVA / |
| LIMON ZVI | 0.06% (11586) | CEVA / DSPG / |
| AYALON ELIYAHU | 0.02% (5086) | CEVA / DSPG / |
| Marced Maria | 0.01% (2770) | CEVA / |
UM